Ventricular Arrhythmia Following Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

American Journal of Cardiology

Volumn 104, Issue 1, 2009, Pages 128-132

  Noseworthy, Peter A ^a   Rosenberg, Michael A ^b   Fifer, Michael A ^a   Palacios, Igor F ^a   Lowry, Patricia A ^a   Ruskin, Jeremy N ^a   Sanborn, Danita M ^a   Picard, Michael H ^a   Vlahakes, Gus J ^a   Mela, Theofanie ^a   Das, Saumya ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL SEPTAL ABLATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR RISK; CATHETER ABLATION; COHORT ANALYSIS; DEFIBRILLATOR; DEVICE THERAPY; FEMALE; FOLLOW UP; HEART ARREST; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SUDDEN DEATH; TREATMENT INDICATION;

ANTI-INFECTIVE AGENTS, LOCAL; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 67649359494     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.056     Document Type: Article

References (16)

1. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
2. Cuoco F.A., Spencer III W.H., Fernandes V.L., Nielsen C.D., Nagueh S., Sturdivant J.L., Leman R.B., Wharton J.M., and Gold M.R. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol 52 (2008) 1718-1723
3. Maron B.J., Spirito P., Shen W.K., Haas T.S., Formisano F., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Lawrenz T., Boriani G., Estes III N.A., Favale S., Piccininno M., Winters S.L., Santini M., Betocchi S., Arribas F., Sherrid M.V., Buja G., Semsarian C., and Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298 (2007) 405-412
4. Boltwood Jr. C.M., Chien W., and Ports T. Ventricular tachycardia complicating alcohol septal ablation. N Engl J Med 351 (2004) 1914-1915
5. Hori Y., Ueda M., Nakayama T., Saegusa N., Uehara M., Lee K., Sekine T., Daimon M., Kobayashi Y., Funabashi N., and Komuro I. Occurrence of de novo sustained monomorphic ventricular tachycardia induced after percutaneous transluminal alcohol septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Int J Cardiol 119 (2007) 403-407
6. McGregor J.B., Rahman A., Rosanio S., Ware D., Birnbaum Y., and Saeed M. Monomorphic ventricular tachycardia: a late complication of percutaneous alcohol septal ablation for hypertrophic cardiomyopathy. Am J Med Sci 328 (2004) 185-188
7. Simon R.D., Crawford III F.A., Spencer III W.H., and Gold M.R. Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Pacing Clin Electrophysiol 28 (2005) 1354-1356
8. Lawrenz T., Obergassel L., Lieder F., Leuner C., Strunk-Mueller C., Meyer Zu Vilsendorf D., Beer G., and Kuhn H. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy. Pacing Clin Electrophysiol 28 (2005) 295-300
9. Guo H., Wang P., Xing Y., Peng F., Jiang J., Yang B., You B., Qiu Y., and Lee J.D. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. J Electrocardiol 40 (2007) e1-e6
10. Kuhn H., Lawrenz T., Lieder F., Leuner C., Strunk-Mueller C., Obergassel L., Bartelsmeier M., and Stellbrink C. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience. Clin Res Cardiol 97 (2008) 234-243
11. Chen A.A., Palacios I.F., Mela T., Yoerger D.M., Picard M.H., Vlahakes G., Lowry P.A., and Fifer M.A. Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol 97 (2006) 264-269
12. Baggish A.L., Smith R.N., Palacios I., Vlahakes G.J., Yoerger D.M., Picard M.H., Lowry P.A., Jang I.K., and Fifer M.A. Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart 92 (2006) 1773-1778
13. Ellenbogen K.A., Levine J.H., Berger R.D., Daubert J.P., Winters S.L., Greenstein E., Shalaby A., Schaechter A., Subacius H., and Kadish A. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?. Circulation 113 (2006) 776-782
14. Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., Cecchi F., and Maron B.J. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
15. Ommen S.R., Maron B.J., Olivotto I., Maron M.S., Cecchi F., Betocchi S., Gersh B.J., Ackerman M.J., McCully R.B., Dearani J.A., Schaff H.V., Danielson G.K., Tajik A.J., and Nishimura R.A. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 46 (2005) 470-476
16. Elliott P.M., Gimeno J.R., Tome M.T., Shah J., Ward D., Thaman R., Mogensen J., and McKenna W.J. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27 (2006) 1933-1941